Dergiler / Cumhuriyet Science Journal / 2021 / Cilt: 42 - Sayı: 2

Examination of 99mTc-mdp radioactivity after ınjection according to time and distance

Sayfa
389–396
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The results obtained were compared with other studies in the literature.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:In nuclear medicine, the imaging process used to diagnose diseases and to examine the functions of organs is carried out with radiopharmaceuticals containing radioisotope.
📊
Temel Bulgular & Veri:In this study, the amount of external radiation emitted from bone scintigraphy patients who were given 99mTc-MDP kit was examined.
💡
Sonuç & Katkı:The results obtained were compared with other studies in the literature.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

In nuclear medicine, the imaging process used to diagnose diseases and to examine the functions of organs is carried out with radiopharmaceuticals containing radioisotope. In this study, the amount of external radiation emitted from bone scintigraphy patients who were given 99mTc-MDP kit was examined. The measurements have been performed using FLUKE Victoreen ASM 990 portable detector at Nuclear Medicine Department Medicine Faculty in Tokat Gaziosmanpasa University. The external dose rate values have been measured at 0.50 m, 1.0 m, 2.0 m and 3.0 m away from the patient considered as the source of radiation. All measurements have been taken within approximately one hour and 10 minutes at 10 minutes intervals after injection of the pharmaceutical. In this study, the highest external dose rate value is measured 13.81 μSv h-1 from 0.50 m distance after 30 minutes from the radiopharmaceutical injection and the lowest external dose rate value 1.53 μSv h-1 is obtained from 3.0 m distance after 60 minutes. Then, dose rate values per unit activity were calculated and the highest value was found as 20.57 μSv h-1 GBq-1 30 minutes after injection at 0.50 m. The results obtained were compared with other studies in the literature.

🔖

Bu Makaleye Atıf Yap

COŞKUN, A., GÖKBULUT, M., DEMİR, F., YİĞİTOĞLU, İ., ÇETİN, B. (2022). Examination of 99mTc-mdp radioactivity after ınjection according to time and distance. Cumhuriyet Science Journal, Cilt: 42 - Sayı: 2, 389–396. https://ajindex.com/articles/477581

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (19)

  1. Saha G. B., Fundamentals of Nuclear Pharmacy, 6nd ed. London: Springer, (2010) 83-100
  2. Lee Y. S., Radiopharmaceuticals for Molecular Imaging, The Open Nuclear Medicine Journal, 2 (2010) 178-185
  3. Grupen C., Buvat I., Handbook of Particle Detection and Imaging, New York: Springer, (2012) 859-881
  4. Teksöz S., Müftüler F. Z., Nükleer Tıpta Kullanılan Radyoizotoplar ve Biyomedikal Uygulamaları, Nuclear Medicine Seminar, 5 (2019) 10-14
  5. Gündoğdu E. A., Özgenç E., Ekinci M., Özdemir D. İ., Aşıkoglu M., Nükleer Tıpta Görüntüleme ve Tedavide Kullanılan Radyofarmasötikler, Journal of Literature Pharmacy Sciences, 7 (1) (2018) 24-34
  6. Subramanian G., McAfee J. G., Blair R. J., KallfeIz F. A., Thomas, F. D., Technetium-99m- Methylene Diphosphonate a Superior Agent for Skeletal İmaging: Comparison with other Technetium Complexes, Journal of Nuclear Medicine, 16 (1975) 744-755
  7. Önsel Ç., Kantarcı F., Görüntüleme Yöntemleri Sempozyumu, İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. Birinci Basım, İstanbul, 2010
  8. Salmanoğlu E., Peksoy İ., Tc-99m MDP’nin intraarteryal enjeksiyonu, Cukurova Medical Journal, 41(1) (2016) 75-78
  9. IAEA., International basic safety standards for protection against ionizing radiation and for the safety of radiation sources, International Atomic Energy Agency. Safety Series No
  10. Vienna, (1996) 20-30
  11. Valantin J., Radiological Protection in Medicine. ICRP Publication 105. Ann. ICRP 3 (2008) 17-22
  12. Eckerman K., Harrison J., Menzel H. G., Clement C. H., Compendium of Dose Coefficients based on ICRP Publication 60. ICRP Publication 119, Ann. ICRP, 41(1) (2011) 13-22
  13. IAEA., Release of Patients After Radionuclide Therapy, International Atomic Energy Agency. Safety Report Series No
  14. Vienna, (2009) 3-15
  15. TAEK., Radyonüklit Tedavisi Gören Hastaların Taburcu Edilmesine İlişkin Kılavuz. Ankara: RSGD-KLV-009 (Rev.2), Türkiye Atom Enerji Kurumu, (2016) 7-22
  16. ASM 990 Series, Advanced Survey Meter, Available at: https://www.flukebiomedical.com/products/radia tion-measurement. Retrieved March 25, 2020
  17. Chabot G., Instrumentation and Measurements Surveys and Measurements (SM), Health Physics Society, Available at: http://hps.org/publicinformation/ate/q4148.html. Retrieved May 25, 2020
  18. Vennart J., Radiation Dose to Patients from Radiopharmaceutcals, ICRP Publication 53. Ann. ICRP, 18 (1-4) (1998) 213-217
  19. Bartlett M. L., Estimated Dose From Diagnos